Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100044575Phase 4Recruiting
Phase 4, randomised trial of phloroglucinol in None (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: antiperistaltic effect of phloroglucinol. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100044575.